Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Papadopoulos

Showing results (161-170 of 288) with videos related to

Pageof 29
Sort By:
The Science of the Total Environment|August 10, 2023
Thirty years of a bottom oxygen depletion-renewal cycle in the coastal yet deep environment of the West Saronikos Gulf (Greece): Its drivers and the impact on the benthic communitiesHarilaos Kontoyiannis, Alexandra Pavlidou, Christina Zeri, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 7, 2005
Adiponectin and resistin plasma levels in healthy individuals with prehypertensionDimitrios P Papadopoulos, Thomas K Makris, Panagiota G Krespi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cellsMasahito Shimizu, Masumi Suzui, Atsuko Deguchi, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancerK P Papadopoulos, J Ayello, R F Reiss, et al.
Journal of Human Hypertension|January 17, 2019
Labile hypertension: a new disease or a variability phenomenon?Elias Sanidas, Charalampos Grassos, Dimitrios P Papadopoulos, et al.
Journal of Environmental Management|November 18, 2022
A semi-continuous algal-bacterial wastewater treatment process coupled with bioethanol productionKonstantinos P Papadopoulos, Christina N Economou, Natassa Stefanidou, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancerK P Papadopoulos, M J Egorin, M Huang, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2020
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumorsKyriakos P Papadopoulos, Nehal Lakhani, Gerald S Falchook, et al.
Human Genetics|January 1, 1989
Ferritin H gene polymorphism in idiopathic hemochromatosisV David, P Papadopoulos, J Yaouanq, et al.
American Journal of Hypertension|August 2, 2005
Human soluble leptin receptor number in healthy normotensive individuals with high normal blood pressureDimitrios P Papadopoulos, Thomas K Makris, Panagiota G Krespi, et al.
Pageof 29

Showing results (161-170 of 288) with videos related to

Sort By:
Pageof 29
The Science of the Total Environment|August 10, 2023
Thirty years of a bottom oxygen depletion-renewal cycle in the coastal yet deep environment of the West Saronikos Gulf (Greece): Its drivers and the impact on the benthic communitiesHarilaos Kontoyiannis, Alexandra Pavlidou, Christina Zeri, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 7, 2005
Adiponectin and resistin plasma levels in healthy individuals with prehypertensionDimitrios P Papadopoulos, Thomas K Makris, Panagiota G Krespi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cellsMasahito Shimizu, Masumi Suzui, Atsuko Deguchi, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancerK P Papadopoulos, J Ayello, R F Reiss, et al.
Journal of Human Hypertension|January 17, 2019
Labile hypertension: a new disease or a variability phenomenon?Elias Sanidas, Charalampos Grassos, Dimitrios P Papadopoulos, et al.
Journal of Environmental Management|November 18, 2022
A semi-continuous algal-bacterial wastewater treatment process coupled with bioethanol productionKonstantinos P Papadopoulos, Christina N Economou, Natassa Stefanidou, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancerK P Papadopoulos, M J Egorin, M Huang, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2020
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumorsKyriakos P Papadopoulos, Nehal Lakhani, Gerald S Falchook, et al.
Human Genetics|January 1, 1989
Ferritin H gene polymorphism in idiopathic hemochromatosisV David, P Papadopoulos, J Yaouanq, et al.
American Journal of Hypertension|August 2, 2005
Human soluble leptin receptor number in healthy normotensive individuals with high normal blood pressureDimitrios P Papadopoulos, Thomas K Makris, Panagiota G Krespi, et al.
Pageof 29